{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T09:11:39Z","timestamp":1788685899787,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"DOI":"10.1007\/s00246-026-04460-4","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:36:17Z","timestamp":1788683777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of Inpatient and Outpatient Beta Blocker Initiation in Pediatric Heart Failure"],"prefix":"10.1007","author":[{"given":"Victor","family":"Benvenuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kroslowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia K.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lorts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Spinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"4460_CR1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-7-200104030-00008","author":"JM Brophy","year":"2001","unstructured":"Brophy JM, Joseph L, Rouleau JL (2001) \u03b2-blockers in congestive heart failure: a Bayesian meta-analysis. Ann Intern Med. https:\/\/doi.org\/10.7326\/0003-4819-134-7-200104030-00008","journal-title":"Ann Intern Med"},{"key":"4460_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.02.020","author":"JW Ostrominski","year":"2024","unstructured":"Ostrominski JW, DeFilippis EM, Bansal K et al (2024) Contemporary American and European guidelines for heart failure management: JACC: heart failure guideline comparison - PubMed. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2024.02.020","journal-title":"JACC Heart Fail"},{"key":"4460_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1171","author":"RE Shaddy","year":"2007","unstructured":"Shaddy RE, Boucek MM, Hsu DT et al Carvedilol for children and adolescents with heart failure: a randomized controlled trial - PubMed. JAMA. https:\/\/doi.org\/10.1001\/jama.298.10.1171","journal-title":"JAMA"},{"key":"4460_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007037.pub4","author":"S Alabed","year":"2020","unstructured":"Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y (2020) Beta-blockers for congestive heart failure in children - PubMed. Cochrane database syst rev. https:\/\/doi.org\/10.1002\/14651858.CD007037.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"4460_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2025.06.003","author":"C Irving","year":"2025","unstructured":"Irving C, Azeka E, Adorisio R et al (2025) The international society for heart and lung transplantation guidelines for the management of pediatric heart failure (Update From 2014) - PubMed. J Heart Lung Transplantation: Official Publication Int Soc Heart Transplantation. https:\/\/doi.org\/10.1016\/j.healun.2025.06.003","journal-title":"J Heart Lung Transplantation: Official Publication Int Soc Heart Transplantation"},{"key":"4460_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.02.015","author":"SJ Greene","year":"2019","unstructured":"Greene SJ, Fonarow GC, DeVore AD Titration of medical therapy for heart failure with reduced ejection fraction - pubMed. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2019.02.015","journal-title":"J Am Coll Cardiol"},{"key":"4460_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.070","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM (2018) Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry - PubMed. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.070","journal-title":"J Am Coll Cardiol"},{"key":"4460_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1263482","author":"G Schurtz","year":"2023","unstructured":"Schurtz G, Mewton N, Lemesle G et al (2023) Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2023.1263482","journal-title":"Front Cardiovasc Med"},{"key":"4460_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2018.06.011","author":"AA Bhagat","year":"2019","unstructured":"Bhagat AA, Greene SJ, Vaduganathan M, Fonarow GC, Butler J (2019) Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2018.06.011","journal-title":"JACC Heart Fail"},{"key":"4460_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.10.008","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Abraham WT, Albert NM et al (2007) Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) - PubMed. Am Heart J. https:\/\/doi.org\/10.1016\/j.ahj.2006.10.008","journal-title":"Am Heart J"},{"key":"4460_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2007.06.727","author":"GC Fonarow","year":"2007","unstructured":"Fonarow GC, Abraham WT, Albert NM et al (2007) Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF - PubMed. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2007.06.727","journal-title":"J Card Fail"},{"key":"4460_CR12","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-09-0993","author":"M Tsuchihashi-Makaya","year":"2010","unstructured":"Tsuchihashi-Makaya M, Kinugawa S, Yokoshiki H et al (2010) Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival - PubMed. Circulation J: official J Japanese Circulation Soc. https:\/\/doi.org\/10.1253\/circj.cj-09-0993","journal-title":"Circulation J: Official J Japanese Circulation Soc"},{"key":"4460_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.12.040","author":"WA Gattis","year":"2004","unstructured":"Gattis WA, O\u2019Connor CM, Gallup DS, Hasselblad V, Gheorghiade M (2004) Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial - PubMed. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2003.12.040","journal-title":"J Am Coll Cardiol"},{"key":"4460_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhlto.2025.100311","author":"LK Wright","year":"2025","unstructured":"Wright LK, Peng DM, Spinner JA et al (2025) Improving pediatric heart failure outcomes through collaboration and innovation: The current status of the Advanced Cardiac Therapies Improving Outcomes Network (ACTION). JHLT Open. https:\/\/doi.org\/10.1016\/j.jhlto.2025.100311","journal-title":"JHLT Open"},{"key":"4460_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100053","author":"N Enzan","year":"2021","unstructured":"Enzan N, Matsushima S, Ide T et al (2021) Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fraction. Am Heart J Plus: Cardiol Res Pract. https:\/\/doi.org\/10.1016\/j.ahjo.2021.100053","journal-title":"Am Heart J Plus: Cardiol Res Pract"},{"key":"4460_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12183","author":"BS Moffett","year":"2015","unstructured":"Moffett BS, Price JF (2015) National prescribing trends for heart failure medications in children - PubMed. Congenital Heart Disease. https:\/\/doi.org\/10.1111\/chd.12183","journal-title":"Congenital Heart Disease"},{"key":"4460_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-020-02485-x","author":"J Stidham","year":"2021","unstructured":"Stidham J, Feingold B, Almond CS et al (2021) Establishing baseline metrics of heart failure medication use in children: a collaborative effort from the ACTION network - PubMed. Pediatr Cardiol. https:\/\/doi.org\/10.1007\/s00246-020-02485-x","journal-title":"Pediatr Cardiol"},{"key":"4460_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2024.10.445","author":"D Nandi","year":"2025","unstructured":"Nandi D, Wright LK, Sublett-Smith J et al (2025) Suboptimal titration of heart failure medications in pediatric patients: baseline data from ACTION - PubMed. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2024.10.445","journal-title":"J Card Fail"},{"key":"4460_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.775","author":"S Paolillo","year":"2017","unstructured":"Paolillo S, Mapelli M, Bonomi A et al (2017) Prognostic role of \u03b2-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.775","journal-title":"Eur J Heart Fail"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04460-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-026-04460-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04460-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:36:18Z","timestamp":1788683778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-026-04460-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":19,"alternative-id":["4460"],"URL":"https:\/\/doi.org\/10.1007\/s00246-026-04460-4","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}